Hello and welcome. It's Eric Erickson here the second hour of the program. The phone number is 877-9-9-7-9-7-9-7-4-25 if you would like to be a part of this year program.

Since we're back and fully operational after the first year, and by the way, I hope you all had a happy New Year.

Why don't we start off with some phone calls? Because I was gone for a few weeks. I miss talking to you people.

And you should know in a programming note at some point in the next hour, like it or not,

the president of the United States is going to be talking. And I will carry, to be short so I will at least we ought to hear

what the president says if we want to laugh at him we should at least hear him but right now

let me go to Pam who's been waiting patiently Pam welcome hello hi there hi what's going on Hello? Hi there. Hi.

What's going on?

So I just was wondering if you knew whether or not it's true that the reason the pharma people want our young children vaccinated is because they have to have that data in order to get liability insurance for the vaccine and for them to cover reactions to the vaccine after it leaves the emergency use

authorization. No. And I know that's not true because there's a federal fund that is set aside for anyone who has a problem with a vaccine.

When a vaccine is produced by a pharmaceutical company in this country, the federal government takes on the liability, not the not the pharmaceutical company.

And this was in large part because in some of the early vaccinations in this country,

when they began mandating the MMR vaccine and stuff,

there are kids who do have reactions.

Now, I want to say that in the last 10 years,

and I'm talking the last 10 American years,

if I remember right, it's like 1,049 kids in a decade had problems with the vaccine for the MMR.

And the federal government pays money for these things, not the, not the, not the, not the

pharmaceutical companies. And in a large part, the reason they do it that way is

because, uh, they don't want for liability purposes and insurance purposes

for the pharmaceutical companies in this country, it would be very, very hard to

figure out, well, what their liability should be. So they don't do that.

...